Related Experiment Video
Updated: Jul 10, 2025

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Vascular endothelial growth factor-D plasma levels in fluid overload and cardiac function evaluation of elderly
Jun Li1,2, Xiao-Lin Li2, Fa-Hu Liu3
1Department of Nephrology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.
Insights
Vascular Endothelial Growth Factor-D (VEGF-D) and Growth Differentiation Factor-15 (GDF-15) show promise as biomarkers for fluid overload and cardiac function in elderly cardiovascular patients. Higher VEGF-D levels correlate with heart failure severity and cardiac function indicators.
Area of Science:
- Cardiology
- Biomarker Discovery
- Geriatric Medicine
Background:
- Cardiovascular disease (CVD) in the elderly presents complex challenges in managing fluid overload and assessing cardiac function.
- Existing biomarkers may not fully capture the intricate pathophysiology of CVD in older populations.
Purpose of the Study:
- To investigate the clinical significance of vascular endothelial growth factor (VEGF) subtypes (VEGF-C, VEGF-D) and growth differentiation factor-15 (GDF-15) plasma levels.
- To evaluate their utility in assessing fluid overload and cardiac function in elderly patients with CVD.
Main Methods:
- Plasma levels of VEGF-C, VEGF-D, and GDF-15 were measured using ELISA in elderly CVD patients.
- Correlations with N-terminal pro B-type natriuretic peptide (NT-pro BNP) and echocardiographic parameters were analyzed.
Main Results:
- Higher plasma levels of VEGF-D and GDF-15 were observed in patients with CVD and heart failure.
- VEGF-D levels positively correlated with NT-pro BNP and echocardiographic indicators of cardiac function and fluid overload.
- GDF-15 levels correlated with biomarkers of cardiac and tubular injury, as well as age, kidney function, and nutritional status.
Conclusions:
- VEGF-D shows potential as a biomarker for fluid overload and cardiac function in elderly CVD patients.
- GDF-15 and NT-pro BNP levels are influenced by age, nutrition, and kidney function, impacting their use in assessing cardiac status.
Abstract:
This study aimed to investigate the clinical significance of vascular endothelial growth factor (VEGF) subtypes and growth differentiation factor-15 (GDF-15) plasma levels in evaluating the fluid overload and cardiac function of elderly patients with cardiovascular disease. The plasma levels of VEGF-C, VEGF-D, and GDF-15 were measured using ELISA. Their correlations with N-terminal pro B-type natriuretic peptide (NT-Pro BNP) and echocardiography data were analyzed. 1. Higher plasma levels of VEGF-D and GDF-15 were observed in elderly patients with cardiovascular disease and heart failure(P < .01). VEGF-D plasma levels were higher in patients with chronic heart failure than those with acute myocardial infarction (P < .01). VEGF-D plasma levels were positively correlated with amino-terminal pro-B type natriuretic peptide (NT-pro BNP) (P < .001). VEGF-D plasma levels were positively correlated with echocardiographic parameters, including left atrial diameter, left ventricular end-diastolic diameter and left ventricular ejection fraction, in patients with cardiovascular disease (P < .01). 2. VEGF-C plasma levels were higher in acute myocardial infarction group (P < .05). The plasma levels of VEGF-C were not correlated with either VEGF-D or NT-pro BNP plasma levels. VEGF-C plasma levels had no correlation with echocardiographic parameters. 3. GDF-15 plasma levels were positively correlated with sera biomarkers of cardiac injury (creatine kinase isoenzyme MB and cardiac troponin I). GDF-15 plasma levels were positively correlated with urinary biomarkers of tubular injury (N-acetyl-β-galactosidase and α1-microglobulin). Both GDF-15 and NT-pro BNP plasma levels were correlated with age, estimated glomerular filtration rate (eGFR), and nutritional biomarkers (albumin and hemoglobin plasma levels). VEGF-D plasma levels is a potential biomarker of fluid overload and cardiac function in elderly patients with cardiovascular disease. Age, nutrition, and kidney injury are factors influencing both GDF-15 and NT-pro BNP plasma levels in estimating cardiac function and fluid overload.
Related Concept Videos
Heart Failure Drugs: Diuretics
Pathophysiology of Heart Failure
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

